Roche grants access to flu vax research

The BMJ, which has been campaigning for full disclosure on Tamiflu (oseltamivir), revealed Roche had contacted Cochrane researchers promising access to each clinical study report from all 74 Roche-sponsored trials.

It was stated that reports will be edited by Roche “to ensure patient confidentiality and to protect legitimate commercial interests”.

The Cochrane group, for whom Australian academic Professor Chris Del Mar is coordinating editor of the Acute Respiratory Infections Group, has cautiously welcomed the move.